Stephen D. Barrett - Concepedia

Author

Stephen D. Barrett

Pfizer (United States)ORCID

Also Known As

Barrett, Stephen D., S. Barrett, S. D. BARRETT, S.D Barrett, S.D. Barrett, Stephen Barrett, Stephen D. Barrett

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)University of Michigan

About

Stephen D. Barrett is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	2K
2	Natural Sciences	4	4	413
3	Biochemistry	3	3	376
4	Engineering	2	2	70
5	Biomolecular Engineering	1	1	37

Stephen D. Barrett

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo Judith S. Sebolt–Leopold, David T. Dudley, Román Herrera, Nature Medicine Colon TumorsMedicineReceptor Tyrosine KinasePathologyColorectal Cancer	1999	965
Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition Jeffrey F. Ohren, Huifen Chen, A.G. Pavlovsky, Nature Structural & Molecular Biology Signal TransductionSignaling PathwayCell RegulationReceptor Tyrosine KinaseMolecular Biology	2004	612
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901 Stephen D. Barrett, Alexander J. Bridges, David T. Dudley, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetBiochemistryNatural SciencesMedicine	2008	280
Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: Potential proinflammatory mechanisms Melissa Thiel, Caralee Schaefer, Mark E. Lesch, Arthritis & Rheumatism	2007	99
2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles—O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase) Joseph S. Warmus, Cathlin Flamme, Lu Yan Zhang, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2008	67
A comparative reactivity study of 1-alkene fuels from ethylene to 1-heptene Shijun Dong, Kuiwen Zhang, P. K. Senecal, Proceedings of the Combustion Institute	2020	57
4-Anilino-5-carboxamido-2-pyridone Derivatives as Noncompetitive Inhibitors of Mitogen-Activated Protein Kinase Kinase Julie A. Spicer, Gordon W. Rewcastle, Michael D. Kaufman, Journal of Medicinal Chemistry	2007	48
New Route to 4-Aminocyclopent-2-en-1-ols: Synthesis and Enantioselective Rearrangement of 4-Amino-substituted Cyclopentene Oxides Stephen D. Barrett, Peter O’Brien, H. Christian Steffens, Tetrahedron Enantioselective RearrangementEngineeringHeterocyclicNatural SciencesDiversity-oriented Synthesis	2000	37
Cross Metathesis on Olefin-Terminated Monolayers on Si(111) Using the Grubbs' Catalyst Samrat Dutta, Mathew Perring, Stephen D. Barrett, Langmuir	2006	34
SN2′ Substitutions of 1,3-Dichloropropenes with the Functionalized Copper-Zinc Reagents RCu(CN)ZnX Gu Chen Huai, Jennifer L. Gage, Stephen D. Barrett, Tetrahedron Letters Materials ScienceInorganic ChemistryEngineeringSn2′ SubstitutionsOrganic Chemistry	1990	33

Page 1